CROWELL, M.; COULTON, K.; JOHNSON, C.; WESTCOTT, J.; BELLOMO, D.; EDELMAN, S., and HIRSCH, E., 2010. An estimate of the U.S. population living in 100-year coastal flood hazard areas. Journal of Coastal Research, 26(2), 201-211. West Palm Beach (Florida), ISSN 0749-0208.The Federal Emergency Management Agency (FEMA) recently completed a coastal demographics study of the United States and U.S. territories. As part of this study, FEMA estimated the United States population subject to the 1% annual chance (100 y) coastal flood hazard as mapped by FEMA. This determination followed a three-step process: (1) create a national digital flood hazard database by compiling the best available coastal-proximate, digital flood-hazard-area data using FEMA data sets; (2) develop a systematic method to separate coastal and riverine flood hazard areas and incorporate this boundary into the digital flood hazard database; and (3) combine the year 2000 census data with the digital flood hazard database using a geographic information system. This enabled estimates of the U.S. population subject to the 1% annual chance coastal flood. The analysis was conducted at the census block-group level, with census block-group populations (permanent residents) assumed to be uniformly distributed across each block group. The results demonstrate that approximately 3.0% of the U.S. population lives in areas subject to the 1% annual chance coastal flood hazard. It must be emphasized, however, that these numbers are based on the 1% annual chance (100 y) coastal flood. Historical coastal floods less frequent than the 1% chance annual flood have occurred in the U.S. on numerous occasions. If less-frequent coastal flood events were considered in this study, such as the 0.2% annual chance (500 y) coastal flood or, if seasonal (vacations) population were considered, then a much greater percentage of the U.S. population would be determined as subject to coastal flooding.
This research was undertaken to evaluate the effects of age and race on prognosis of patients with endometrial carcinoma. A total of 279 patients with endometrial carcinoma treated at State University of New York-Health Science Center and Kings County Hospital Brooklyn, New York from 1975 to 1990 were retrospectively analyzed. Patients were arbitrarily divided into young and old groups (< or = 60 years or > 60 years old, respectively). The distribution of grade, clinical stage, and extent of myometrial invasion by age was determined for the entire group and for black and white patients, respectively. Young and old patients were stratified by clinical stage, grade, and extent of myometrial invasion. The corrected median survival of young and old patients by race was evaluated by Kaplan Meier's method of analysis. Older patients in general had higher clinical stage, higher grade, and greater depth of myometrial invasion than younger patients. Also, black patients had higher clinical stage, higher grade, and greater depth of myometrial invasion than white patients. Older black patients had the least favorable distribution of prognostic factors. Overall younger patients had a median survival of 200 months compared to 90 months for older patients (p = 0.0085). The overall corrected median survival for whites was 232 months compared to 108 months for blacks (p = 0.0001). The median survival of older black patients was worst at 40 months, compared to 155 months for older white patients (p = 0.0005). Age is a very important prognostic factor in endometrial carcinoma for both blacks and whites, and it appears to be more pronounced in older black patients.
This retrospective analysis reveals a very good outcome and an acceptable toxicity profile for patients with locally advanced SCC of the oropharynx and larynx treated with chemotherapy and IMRT concurrently.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.